These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30239840)

  • 1. Intratumoral Heterogeneity of Glioblastoma Infiltration Revealed by Joint Histogram Analysis of Diffusion Tensor Imaging.
    Li C; Wang S; Yan JL; Piper RJ; Liu H; Torheim T; Kim H; Zou J; Boonzaier NR; Sinha R; Matys T; Markowetz F; Price SJ
    Neurosurgery; 2019 Oct; 85(4):524-534. PubMed ID: 30239840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.
    Yan JL; van der Hoorn A; Larkin TJ; Boonzaier NR; Matys T; Price SJ
    J Neurosurg; 2017 Jan; 126(1):234-241. PubMed ID: 27058207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value.
    Hwang I; Choi SH; Park CK; Kim TM; Park SH; Won JK; Kim IH; Lee ST; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    AJNR Am J Neuroradiol; 2020 Jan; 41(1):49-56. PubMed ID: 31806595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Texture analysis on diffusion tensor imaging: discriminating glioblastoma from single brain metastasis.
    Skogen K; Schulz A; Helseth E; Ganeshan B; Dormagen JB; Server A
    Acta Radiol; 2019 Mar; 60(3):356-366. PubMed ID: 29860889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
    Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
    Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subventricular Zone Involvement Characterized by Diffusion Tensor Imaging in Glioblastoma.
    van Dijken BRJ; Yan JL; Boonzaier NR; Li C; van Laar PJ; van der Hoorn A; Price SJ
    World Neurosurg; 2017 Sep; 105():697-701. PubMed ID: 28642175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma.
    Li C; Wang S; Serra A; Torheim T; Yan JL; Boonzaier NR; Huang Y; Matys T; McLean MA; Markowetz F; Price SJ
    Eur Radiol; 2019 Sep; 29(9):4718-4729. PubMed ID: 30707277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional Anisotropy Correlates with Overall Survival in Glioblastoma.
    Huber T; Bette S; Wiestler B; Gempt J; Gerhardt J; Delbridge C; Barz M; Meyer B; Zimmer C; Kirschke JS
    World Neurosurg; 2016 Nov; 95():525-534.e1. PubMed ID: 27565465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor at Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma.
    Gagnon L; Gupta D; Mastorakos G; White N; Goodwill V; McDonald CR; Beaumont T; Conlin C; Seibert TM; Nguyen U; Hattangadi-Gluth J; Kesari S; Schulte JD; Piccioni D; Schmainda KM; Farid N; Dale AM; Rudie JD
    Radiol Artif Intell; 2024 Sep; 6(5):e230489. PubMed ID: 39166970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
    Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
    J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma.
    Choi YS; Ahn SS; Kim DW; Chang JH; Kang SG; Kim EH; Kim SH; Rim TH; Lee SK
    Radiology; 2016 Oct; 281(1):175-84. PubMed ID: 27120357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric model for discrimination between glioblastoma multiforme and solitary metastasis using three-dimensional shape analysis.
    Yang G; Jones TL; Howe FA; Barrick TR
    Magn Reson Med; 2016 Jun; 75(6):2505-16. PubMed ID: 26173745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.
    Rahman R; Hamdan A; Zweifler R; Jiang H; Norden AD; Reardon DA; Mukundan S; Wen PY; Huang RY
    J Neurooncol; 2014 Aug; 119(1):149-58. PubMed ID: 24805151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden.
    Patel KS; Everson RG; Yao J; Raymond C; Goldman J; Schlossman J; Tsung J; Tan C; Pope WB; Ji MS; Nguyen NT; Lai A; Nghiemphu PL; Liau LM; Cloughesy TF; Ellingson BM
    Neurosurgery; 2020 Oct; 87(5):931-938. PubMed ID: 32365185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficient histogram analysis for prediction of prognosis in glioblastoma.
    Kondo M; Uchiyama Y
    J Neuroradiol; 2018 Jul; 45(4):236-241. PubMed ID: 29274693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
    Park JE; Kim HS; Park SY; Jung SC; Kim JH; Heo HY
    Radiology; 2020 May; 295(2):397-406. PubMed ID: 32154775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep learning derived tumor infiltration maps for personalized target definition in Glioblastoma radiotherapy.
    Peeken JC; Molina-Romero M; Diehl C; Menze BH; Straube C; Meyer B; Zimmer C; Wiestler B; Combs SE
    Radiother Oncol; 2019 Sep; 138():166-172. PubMed ID: 31302391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of occult neoplastic infiltration in the corpus callosum and prediction of overall survival in patients with glioblastoma using diffusion tensor imaging.
    Mohan S; Wang S; Coban G; Kural F; Chawla S; O'Rourke DM; Poptani H
    Eur J Radiol; 2019 Mar; 112():106-111. PubMed ID: 30777198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
    Zolal A; Juratli TA; Linn J; Podlesek D; Sitoci Ficici KH; Kitzler HH; Schackert G; Sobottka SB; Rieger B; Krex D
    J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.